Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.23.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2023
Stock-Based Compensation  
Stock-based Compensation

Note 7 – Stock-Based Compensation

 

a) Warrants

 

The following table summarizes the changes in warrants outstanding of the Company during the three-month period ended March 31, 2023:

 

 

 

Number of Warrants 

 

 

 Weighted

Average Exercise

Price ($)

 

Outstanding at December 31, 2022

 

 

539,000

 

 

 

3.80

 

Expired/Cancelled

 

 

(125,000 )

 

 

2.47

 

Outstanding at March 31, 2023

 

 

414,000

 

 

 

4.20

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2023

 

 

360,000

 

 

 

4.37

 

 

Below is a table summarizing the warrants issued and outstanding as of March 31, 2023, which have an aggregate weighted average remaining contractual life of 3.92 years.

 

Number

Outstanding 

 

 

Number

Exercisable 

 

 

Exercise

Price ($) 

 

 

Weighted Average Remaining Contractual Life (Years) 

 

 

 Proceeds to

Company if Exercised ($)

 

 

54,000

 

 

 

-

 

 

 

3.05

 

 

 

5.52

 

 

 

164,700

 

 

50,000

 

 

 

50,000

 

 

 

3.45

 

 

 

2.92

 

 

 

172,500

 

 

125,000

 

 

 

125,000

 

 

 

3.95

 

 

 

3.76

 

 

 

493,750

 

 

185,000

 

 

 

185,000

 

 

 

4.90

 

 

 

3.84

 

 

 

906,500

 

 

414,000

 

 

 

360,000

 

 

 

 

 

 

 

 

 

 

 

1,737,450

 

 

Stock-based compensation expense related to warrants of $14,920 and $39,013 was recorded in the three months ended March 31, 2023 and March 31, 2022, respectively. Total remaining unrecognized compensation cost related to non-vested warrants is $20,893 and is expected to be recognized over a period of 1.01 years. As of March 31, 2023, the total intrinsic value of warrants outstanding was $nil.

b) Options

 

The following table summarizes the changes in options outstanding of the Company during the three-month period ended March 31, 2023:

 

 

 

Number of

Options

 

 

Weighted Average Exercise Price ($)

 

Outstanding at December 31, 2022

 

 

4,985,105

 

 

 

3.87

 

Expired/Cancelled

 

 

(268,750 )

 

 

3.90

 

Outstanding at March 31, 2023

 

 

4,716,355

 

 

 

3.87

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2023

 

 

4,226,261

 

 

 

3.93

 

 

Below is a table summarizing the options issued and outstanding as of March 31, 2023, all of which were issued pursuant to the Company’s 2011 Plan (for option issuances prior to 2016) or the 2015 Plan (for option issuances commencing in 2016)and which have an aggregate weighted average remaining contractual life of 4.99 years. As of March 31, 2023, an aggregate of  7,750,000 shares of common stock were authorized for issuance under the 2015 Plan, of which  574,398 shares of common stock remained available for future issuance thereunder.

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price ($)

 

 

Weighted Average Remaining Contractual Life (Years)

 

 

Proceeds to Company if Exercised ($)

 

 

585,000

 

 

 

585,000

 

 

 

3.25

 

 

 

1.87

 

 

 

1,901,250

 

 

2,717

 

 

 

2,717

 

 

 

3.35

 

 

 

0.42

 

 

 

9,102

 

 

990,204

 

 

 

500,110

 

 

 

3.40

 

 

 

8.35

 

 

 

3,366,694

 

 

740,000

 

 

 

740,000

 

 

 

3.60

 

 

 

7.11

 

 

 

2,664,000

 

 

1,607,837

 

 

 

1,607,837

 

 

 

4.00

 

 

 

3.49

 

 

 

6,431,348

 

 

5,434

 

 

 

5,434

 

 

 

4.35

 

 

 

0.42

 

 

 

23,638

 

 

89,163

 

 

 

89,163

 

 

 

4.38

 

 

 

4.82

 

 

 

390,534

 

 

50,000

 

 

 

50,000

 

 

 

4.80

 

 

 

3.76

 

 

 

240,000

 

 

646,000

 

 

 

646,000

 

 

 

5.00

 

 

 

3.99

 

 

 

3,230,000

 

 

4,716,355

 

 

 

4,226,261

 

 

 

 

 

 

 

 

 

 

 

18,256,566

 

b) Options (continued)

 

Stock-based compensation expense related to stock options of $117,034 and $394,053 was recorded in the three months ended March 31, 2023 and March 31, 2022, respectively. Total remaining unrecognized compensation cost related to non-vested stock options is $170,329 and is expected to be recognized over a period of 0.51 years. As of March 31, 2023, the total intrinsic value of stock options outstanding was $nil.

 

c) Restricted Stock Units

 

Below is a table summarizing the RSUs issued and outstanding as of March 31, 2023, all of which were issued pursuant to the 2015 Plan.

 

 

 

Number of

RSUs 

 

 

Weighted

Average Share

Price ($)

 

Outstanding at December 31, 2022

 

 

2,262,908

 

 

 

1.77

 

Granted

 

 

112,325

 

 

 

1.72

 

Vested/Settled

 

 

(34,000 )

 

 

3.16

 

Outstanding at March 31, 2023

 

 

2,341,233

 

 

 

1.74

 

 

Below is a table summarizing the RSUs granted during the three months ended March 31, 2023, all of which were issued pursuant to the 2015 Stock Incentive Plan. The RSUs vest equally over periods stated on the dates noted, subject to continued service, and will result in the RSU compensation expense stated.

 

Equity 

Incentive  Plan

 

RSUs # 

 

 

Grant Date

 

Vesting

Period

 

First Vesting

Date

 

Second Vesting

Date

 

 

Third Vesting

Date

 

 

RSU

Expense $

 

2015

 

 

57,000

 

 

 Mar 27, 2023

 

36 Months

 

 Mar 27, 2024

 

 Mar 27, 2025

 

 

 Mar 27, 2026

 

 

 

98,040

 

2015

 

 

50,000

 

 

 Mar 27, 2023

 

24 Months

 

 Mar 27, 2024

 

 Mar 27, 2025

 

 

 

N/A

 

 

 

86,000

 

2015

 

 

5,325

 

 

 Mar 27, 2023

 

12 Months

 

 Mar 27, 2024

 

 

N/A

 

 

 

N/A

 

 

 

9,159

 

 

 

 

112,325

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

193,199

 

 

Below is a table summarizing the RSUs vested and settled during the three months ended March 31, 2023, all of which were issued pursuant to the 2015 Plan.

 

Equity Incentive Plan

 

 

RSUs

Vested (#)

 

 

 Vest Date

 

Shares

Issued (#) 

 

 

Shares Withheld for

Taxes (#)

 

2015

 

 

15,000

 

 

 Mar 25, 2023

 

 

15,000

 

 

 

-

 

2015

 

 

4,000

 

 

 Feb 8, 2023

 

 

2,369

 

 

 

1,631

 

2015

 

 

15,000

 

 

 Mar 1, 2023

 

 

9,609

 

 

 

5,391

 

 

 

 

34,000

 

 

 

 

 

26,978

 

 

 

7,022

 

c) Restricted Stock Units (continued)

 

Below is a table summarizing the RSUs issued and outstanding as of March 31, 2023 and which have an aggregate weighted average remaining contractual life of 1.57 years.

 

Number

Outstanding

 

 

Weighted Average

Grant date Fair

Value Share Price ($)

 

 

Weighted Average

Remaining

Contractual Life (Years)

 

 

450,000

 

 

 

0.69

 

 

 

3.01

 

 

1,133,000

 

 

 

1.46

 

 

 

1.51

 

 

25,000

 

 

 

1.69

 

 

 

0.98

 

 

112,325

 

 

 

1.72

 

 

 

1.76

 

 

63,102

 

 

 

2.01

 

 

 

0.83

 

 

3,000

 

 

 

2.15

 

 

 

1.67

 

 

33,000

 

 

 

2.45

 

 

 

0.67

 

 

15,000

 

 

 

2.81

 

 

 

0.92

 

 

4,000

 

 

 

2.83

 

 

 

0.86

 

 

136,000

 

 

 

2.95

 

 

 

0.73

 

 

19,904

 

 

 

3.04

 

 

 

0.26

 

 

311,152

 

 

 

3.31

 

 

 

0.35

 

 

12,000

 

 

 

3.32

 

 

 

0.44

 

 

2,000

 

 

 

3.38

 

 

 

0.35

 

 

21,750

 

 

 

3.51

 

 

 

0.29

 

 

2,341,233

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense related to RSUs of $524,892 and $481,962 was recorded in the three months ended March 31, 2023 and March 31, 2022, respectively. Total remaining unrecognized compensation cost related to non-vested RSUs is $1,883,199.